What Aestura does

Aestura is a South Korean dermocosmetic brand owned by Amorepacific (KRX: 090430), specializing in skincare formulated for sensitive skin. Its product portfolio is organized into two distribution channels: a consumer line under the AESTURA 365 umbrella comprising five sub-brands (ATOBARRIER365, THERACNE365, REGEDERM365, A-CICA365, and DERMA UV365), and a hospital/clinic channel offering medical-device and professional-grade formulations such as DERMA BABYPRO MD, A-CICAPRO, and DERMA SCALPPRO. The brand's technical differentiation rests on proprietary complexes including the BMF Complex (30 natural moisturizing factors), pH4.5CICATM Complex, and Triple Lipid Complex (ceramides, fatty acids, cholesterol), with its flagship Atobarrier365 Cream having surpassed 10 million cumulative units sold globally.

The business operates through three primary revenue streams: consumer product sales via Sephora retail (680+ stores across 17 European countries plus US presence) and the aestura.com direct-to-consumer site, hospital/clinic sales of medical-grade products in Korea, and a regular-delivery subscription service offering frequency-based discounts. Since its February 2025 US launch at Sephora, Aestura has scaled rapidly to become one of the retailer's fastest-growing skincare brands and a category leader in dermatologist-recommended skincare. The brand claims the #1 dermatologist-recommended dermocosmetic position in Korea, supported by Coveteur 2026 Beauty Awards and Good Housekeeping Beauty Awards recognition, and benefits from Amorepacific's broader K-beauty corporate infrastructure including cross-promotional partnerships such as the Korea Tourism Organization's 'Korea Now' campaign.

Name

Aestura

Legal name

주식회사 아모레퍼시픽 (Amorepacific Inc.)

Website

https://aestura.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

Aestura is a South Korean dermocosmetic brand under Amorepacific that develops and sells sensitive-skin skincare products (ATOBARRIER365, A-CICA365, THERACNE365, REGEDERM365, DERMA UV365) through Sephora retail, hospital/clinic channels in Korea, and direct e-commerce, serving consumers seeking dermatologist-recommended barrier-care formulations.

Ownership category

akta.pro rank

Product category

Dermocosmetic Skincare

NAICS

Soap and Cleaning Compound Manufacturing (32561), Health and Personal Care Retailers (4561)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844)

akta.pro primary industry

Dermocosmetics & Medical-Grade Skincare (CRABAAAF)

akta.pro secondary industries

Sensitive Skin & Barrier Repair (CRABAAAG), Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Dermatology OTC & Skin Health (Acne Treatments, Eczema/Psoriasis OTC, Antifungals, Wart Removal) (CRADAMAF)

Keywords

• Dermocosmetic skincare
• Sensitive skin care
• Barrier repair moisturizer
• Ceramide skincare products
• Korean skincare brand

Headquarters

HQ city

Yongsan

HQ country

South Korea

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

1. Product Sales (Retail): Revenue generated through sale of dermocosmetic skincare products via Sephora retail stores across Europe and the US, and through Aestura's own e-commerce platform. Products include the ATOBARRIER365 line, A-CICA365 collection, THERACNE365, REGEDERM365, and DERMA UV365.
2. Hospital/Clinic Sales: Direct sales of medical-grade skincare products through dermatologist clinics and hospitals in Korea, including prescription-strength formulations like DERMA BABYPRO(MD) and ATOBARRIER(MD) medical devices.
3. Subscription (Regular Delivery Service): Aestura offers a regular delivery subscription service where customers can schedule automatic monthly shipments with increasing discount benefits for higher shipping frequency. Special programs available for parenting mothers.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Aestura develops, manufactures, and sells dermocosmetic skincare products formulated for sensitive skin, organized into two distinct lines: the AESTURA 365 consumer range (ATOBARRIER365, THERACNE365, REGEDERM365, A-CICA365, DERMA UV365) sold through Sephora retail (US and Europe), Sephora online, and Aestura's own DTC website, plus a hospital/clinical line of medical devices and professional cosmetics (DERMA BABYPRO MD, ATOBARRIER MD, DERMA UVPRO, A-CICAPRO, DERMA SCALPPRO) distributed through Korean dermatology clinics and hospitals. Offerings are built on proprietary complexes (BMF, pH4.5CICATM, Triple Lipid Complex) and a derma-lab quality system rooted in pharmaceutical heritage.

Product overview

Aestura is a Korean derma skincare brand under Amorepacific offering a comprehensive portfolio of sensitive skin care products organized into two main distribution channels. The AESTURA 365 consumer line includes five sub-brands: ATOBARRIER365 (high-density ceramide barrier repair with flagship Atobarrier365 Cream at 10M+ cumulative sales), THERACNE365 (acne care), REGEDERM365 (regenerative care), A-CICA365 (soothing complex featuring pH4.5CICATM), and DERMA UV365 (UV protection). The hospital/clinical sales channel offers medical device and cosmetic products including DERMA BABYPRO, DERMA UVPRO, A-CICAPRO, DERMA SCALPPRO, and ATOBARRIER. The brand emphasizes pharmaceutical heritage, cutting-edge derma lab technology, and quality control optimized for sensitive skin.

Differentiator

Problem solved

Functional benefit

Brands

• AESTURA 365: Main consumer product line featuring barrier care products including ATOBARRIER365, THERACNE365, REGEDERM365, A-CICA365, and DERMA UV365.
• AESTURA 병원판매상품

Products and services

• ATOBARRIER365 Consumer barrier-repair skincare line featuring high-density ceramide capsule technology for intensive moisture and skin barrier reinforcement, designed for consumers with sensitive skin and sold through Sephora and Aestura's DTC channel.
• ATOBARRIER365 Cream Flagship high-density ceramide capsule moisturizing cream — core barrier-repair moisturizer for sensitive skin that has surpassed 10 million cumulative units sold globally.
• ATOBARRIER365 Hydro Essence Lightweight hydrating essence for warm weather featuring the proprietary BMF complex of 30 natural moisturizing factors, designed for barrier hydration in spring/summer use.
• ATOBARRIER365 Lotion Lightweight moisturizing lotion using the Triple Lipid Complex of ceramides, fatty acids, and cholesterol, formulated for lightweight moisture locking during spring/summer.
• THERACNE365 Consumer acne-care skincare line for troubled and acne-prone skin, part of the AESTURA 365 daily skincare system.
• REGEDERM365 Consumer regenerative skincare line for skin recovery and restoration, part of the AESTURA 365 daily skincare system.
• A-CICA365 Soothing skincare collection featuring the proprietary pH4.5CICATM complex designed to soothe sensitive skin and visibly reduce redness; U.S.-exclusive launch through Sephora in February 2026.
• DERMA UV365 Consumer dermatological UV-protection line providing daily sun defense as part of the AESTURA 365 skincare system.
• DERMA BABYPRO Baby skincare line offered in both medical-device (DERMA BABYPRO MD) and cosmetic versions, optimized for sensitive infant skin and sold through the hospital/clinical channel.
• DERMA UVPRO Medical-grade UV-protection product for sensitive skin, available exclusively through the hospital/clinical sales channel in Korea.
• A-CICAPRO Professional-grade cica (centella asiatica) skincare formulation for sensitive-skin repair, distributed through the hospital/clinical sales channel.
• DERMA SCALPPRO Scalp-care product line for the dermatological treatment of scalp conditions, available through the hospital/clinical sales channel.
• ATOBARRIER (MD) and ATOBARRIER (Hospital Cosmetic) Hospital-channel ceramide barrier products available in both medical-device (ATOBARRIER MD) and professional cosmetic variants, sold exclusively through Korean dermatology clinics and hospitals.
• Aestura Regular Delivery Subscription Service (정기배송) Recurring subscription service on Aestura's DTC website that schedules automatic monthly shipments with tiered discount benefits tied to shipping frequency, plus a dedicated parenting-mother subscription program.

Quantifiable outcome

• 10 million+ units sold of Atobarrier365 Cream
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Sephora EuropecoreChannel Partner/ Reseller/ Distributor · 9 March 2026Amorepacific expanded Aestura into approximately 680 Sephora brick-and-mortar stores across 17 European countries, including France, Germany, Italy, and Spain, following the brand's debut on Sephora's European online platform in February 2025. The expansion aims to capitalize on the growing global popularity of K-beauty while strengthening Aestura's international presence.
• SephoracoreChannel Partner/ Reseller/ Distributor · 3 February 2026Aestura launched its A-CICA365 collection exclusively through Sephora in the US (online from February 21, 2026, in stores from February 27, 2026), expanding upon the successful partnership that began in February 2025. Since launching at Sephora, Aestura has become one of the retailer's fastest-growing skincare brands and a leader in the dermatologist skincare category.
• Korea Tourism OrganizationminorGTM or Marketing Partner · 23 October 2025Amorepacific partnered with the Korea Tourism Organization (KTO) for the 'Korea Now: All You Imagine' campaign, including a sweepstakes and pop-up event in New York to promote Korean culture, travel, and beauty, with activities centered around Amorepacific's brands including Aestura.

Scale indicators6 records

Recent moves7 records

Expansion highlights4 records

Direct peers

• La Roche-Posay: La Roche-Posay is L'Oréal's flagship dermocosmetic brand formulated for sensitive skin, with strong dermatologist endorsement globally. It is the closest direct competitor to Aestura in terms of positioning (medical heritage + sensitive-skin focus), pricing tier, and distribution in pharmacies and prestige retail.
• CeraVe: CeraVe (L'Oréal) competes directly with Aestura in ceramide-centric barrier-repair skincare for sensitive skin, with a heavy dermatologist-recommendation model and broad mass-prestige distribution including Sephora. It represents the benchmark for scaling sensitive-skin dermatology brands into global household names.
• Avène: Avène (Pierre Fabre) is a French dermocosmetic brand built around thermal spring water and sensitive-skin formulations with a strong pharmacy heritage. It is directly comparable to Aestura in its pharmaceutical-rooted, sensitive-skin positioning and is sold in both dermatology and prestige retail channels globally.
• Eucerin: Eucerin (Beiersdorf) is a medical skincare brand focused on dermatological conditions including sensitive, dry, and atopic skin. It competes with Aestura for dermatologist recommendation share and shelf space in pharmacies and prestige retail across Europe and the US.
• Bioderma: Bioderma (NAOS) is a French dermo-cosmetic brand with deep sensitive-skin and dermatology credentials, distributed across European pharmacies. It is comparable to Aestura in its reliance on dermatological heritage, ingredient-led formulation philosophy, and pharmacy/prestige dual-channel strategy.
• Dr. Jart+: Dr. Jart+ is a Korean derma-inspired skincare brand (Estée Lauder-owned) sold through Sephora globally. It is one of the most direct Korean precedents for Aestura's premium sensitive-skin positioning at Sephora and competes head-to-head on shelf space and consumer mindshare.
• Vanicream: Vanicream is a US dermatologist-recommended sensitive-skin brand with a stripped-down, hypoallergenic formulation philosophy. It is a direct comparator to Aestura in the US market on dermatologist endorsement, sensitive-skin efficacy claims, and pharmacy/prestige retail positioning.
• CosRx: CosRx is a Korean skincare brand specializing in acne, sensitive, and barrier-repair formulations with a strong Sephora and DTC US presence. It overlaps with Aestura's THERACNE365 and barrier-repair lines and competes for the same TikTok-driven Gen-Z and Millennial K-beauty consumer.

Emerging players

• Skin1004: Skin1004 is a fast-growing Korean skincare brand with sensitive-skin and centella-asiatica-led formulations, expanding through Sephora and DTC channels. It is an emerging peer competing for similar K-beauty shelf space, though with a smaller product portfolio and earlier international stage than Aestura.

Broad incumbents

• Cetaphil: Cetaphil (Galderma) is a mass-market sensitive-skin brand with deep dermatologist endorsement and ubiquitous pharmacy distribution. While it sits at a lower price tier than Aestura, it competes for the same end consumer need (gentle, dermatologist-recommended skincare) and is the broader incumbent Aestura must differentiate against in mass-prestige channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/results?search_query=aestura
• Facebookfacebook.com/aestura

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aestura